CRS-0393

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameCRS-0393

Drug Alias NameCRS-0393

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCell wall inhibitorsMembrane proteins inhibitors

TargetsMembrane proteins

Therapy Area/IndicationsMycobacterium Infections, Nontuberculous

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCrestone Inc

China Registration ClassN/A

Active CompaniesCrestone Inc

Inactive CompaniesN/A

Active IndicationsMycobacterium Infections, Nontuberculous

Inactive IndicationsN/A

ATC CodeN/A